The first potent COQ8 inhibitor targets ubiquinone biosynthesis
The first potent COQ8 inhibitor targets ubiquinone biosynthesis: Inhibition of the COQ8 protein could be beneficial in the treatment of diseases…
inflammatory diseases
Australia-wide COVID study
Australia-wide COVID study: Australians who have recovered from COVID-19 are being called on by researchers to help unravel the mystery…